Innocenti Alessandro, Susini Pietro, Grimaldi Luca, Susini Tommaso
Plastic and Reconstructive Microsurgery, Careggi University Hospital, Florence, Italy.
Plastic Surgery Unit, Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.
Front Oncol. 2024 Jan 8;13:1332862. doi: 10.3389/fonc.2023.1332862. eCollection 2023.
Pregnancy-associated breast cancer (PABC), with an incidence rate from 1:3,000 to 1:10,000 deliveries, is the most frequent cancer during pregnancy. PABC appropriate management must take into consideration both the maternal oncological safety and the fetal health, thus posing a challenge for the mother, the baby, and the clinicians. The treatment should adhere as closely as possible to the breast cancer (BC) guidelines. Therefore, surgery is a mainstay, and, when mastectomy is required, breast reconstruction (BR) is a topic of debate. To minimize the risks to the baby, most surgeons postpone BR to delivery. However, a delayed breast reconstruction (DBR) could affect the outcome. In the present case, we report cesarean section concurrent with mastectomy and immediate breast reconstruction (IBR).
A 37-year-old patient, at the 36th week of pregnancy with PABC, underwent simultaneous cesarean delivery, nipple-sparing mastectomy, and IBR. To minimize risks for the newborn, cesarean was firstly performed under spinal anesthesia. Immediately after, breast surgery, including mastectomy and IBR, was performed under general anesthesia. Partial submuscular IBR with an acellular porcine dermal matrix concluded the surgical procedure. Lactation was inhibited, and adjuvant chemotherapy and hormone therapy were administered to the patient.
In a single surgical session, cesarean delivery, subcutaneous mastectomy, axillary dissection, and IBR were successfully carried out. No early or late postoperative complications were reported for both the patient and the newborn. Histopathological investigation reported a multifocal and multicentric infiltrating ductal carcinoma. After a 6-year follow-up, the patient is alive and well.
To the best of our knowledge, this is the first reported case of concomitant cesarean delivery, PABC mastectomy, axillary dissection, and IBR. This surgical strategy allowed PABC treatment by the BC guideline, minimizing the newborn's disadvantage and permitting, at the same time, the best final BR outcome.
妊娠相关乳腺癌(PABC)的发病率为1:3000至1:10000次分娩,是孕期最常见的癌症。PABC的恰当管理必须兼顾母亲的肿瘤学安全性和胎儿健康,因此对母亲、婴儿和临床医生而言都是一项挑战。治疗应尽可能遵循乳腺癌(BC)指南。所以,手术是主要治疗手段,当需要进行乳房切除术时,乳房重建(BR)则是一个有争议的话题。为将对婴儿的风险降至最低,大多数外科医生会将BR推迟至分娩后进行。然而,延迟乳房重建(DBR)可能会影响治疗效果。在本病例中,我们报告了剖宫产同时行乳房切除术及即刻乳房重建(IBR)的情况。
一名37岁妊娠36周的PABC患者,同时接受了剖宫产、保留乳头的乳房切除术及IBR。为将对新生儿的风险降至最低,首先在脊髓麻醉下进行剖宫产。随后,立即在全身麻醉下进行乳房手术,包括乳房切除术及IBR。手术最后采用脱细胞猪真皮基质进行部分肌下IBR。对患者进行了泌乳抑制,并给予辅助化疗和激素治疗。
在一次手术中,成功实施了剖宫产、皮下乳房切除术、腋窝淋巴结清扫术及IBR。患者和新生儿均未报告早期或晚期术后并发症。组织病理学检查报告为多灶性和多中心浸润性导管癌。经过6年随访,患者存活且情况良好。
据我们所知,这是首例报告的剖宫产、PABC乳房切除术、腋窝淋巴结清扫术及IBR同时进行的病例。这种手术策略允许按照BC指南对PABC进行治疗,将新生儿的不利影响降至最低,同时实现最佳的最终BR效果。